Elinzanetant, antagonista selettivo dei recettori della neurochinina 1 (NK1) e 3 (NK3), ha portato a un rapido miglioramento ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback